|
VYGR Voyager Therapeutics Inc 1640266 |
| Balance Sheet |
|
Current Assets
|
373,443,000 |
|
Assets
|
426,041,000 |
|
Current Liabilities
|
44,210,000 |
|
Liabilities
|
95,731,000 |
|
Equity
|
330,310,000 |
|
Shares Out
|
54,533,000 |
| Cash Flow Statement |
|
Operating Cash Flow
|
-781,000 |
|
Investing Cash Flow
|
-67,656,000 |
| Market Analysis |
Market Cap
|
419,906,014 |
|
Price
|
5.07 |
|
BVPS
|
6.06 |
|
PB
|
0.84 |
|
EPS
|
0.15 |
|
PE
|
50.19 |
|
PS
|
4.26 |
|
FCF
|
-68,437,000 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view VYGR documents filed with the SEC.
VYGR Filings
Clear
